Evidence map›Paper›PMID 36426826›Full record

ArticleThe Journal of pathology2023

Lymphoma-associated mutations in autoreactive memory B cells of patients with Sjögren's syndrome.

Richard J Bende, Linda M Slot, Mark J Kwakkenbos, Thera Am Wormhoudt, Aldo Jongejan, Gwenny M Verstappen, Antoine Cm van Kampen, Jeroen Ej Guikema, Frans Gm Kroese, Carel Jm van Noesel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Richard J Bende *Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-5173-3138
Linda M Slot *Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Mark J KwakkenbosAIMM Therapeutics, Amsterdam, The Netherlands.
Thera Am WormhoudtDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Aldo JongejanBioinformatics Laboratory, Epidemiology & Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Gwenny M VerstappenDepartment of Rheumatology and Clinical Immunology, UMC Groningen, University of Groningen, Groningen, The Netherlands.
Antoine Cm van KampenBioinformatics Laboratory, Epidemiology & Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jeroen Ej GuikemaDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Frans Gm KroeseDepartment of Rheumatology and Clinical Immunology, UMC Groningen, University of Groningen, Groningen, The Netherlands.
Carel Jm van NoeselDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-7907-7390
Dutch Cancer Society · NLUniversity Medical Center Groningen · NLAIMM Therapeutics (Netherlands) · NLAmsterdam University Medical Centers · NLNetherlands Institute for Neuroscience · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently demonstrated that normal memory B lymphocytes carry a substantial number of de novo mutations in the genome. Here, we performed exome-wide somatic mutation analyses of bona fide autoreactive rheumatoid factor (RF)-expressing memory B cells retrieved from patients with Sjӧgren's syndrome (SS). The amount and repertoire of the de novo exome mutations of RF B cells were found to be essentially different from those detected in healthy donor memory B cells. In contrast to the mutation spectra of normal B cells, which appeared random and non-selected, the mutations of the RF B cells were greater in number and enriched for mutations in genes also found mutated in B-cell non-Hodgkin lymphomas. During the study, one of the SS patients developed a diffuse large B-cell lymphoma (DLBCL) out of an RF clone that was identified 2 years earlier in an inflamed salivary gland biopsy. The successive oncogenic events in the RF precursor clone and the DLBCL were assessed. In conclusion, our findings of enhanced and selected genomic damage in growth-regulating genes in RF memory B cells of SS patients together with the documented transformation of an RF-precursor clone into DLBCL provide unique novel insight into the earliest stages of B-cell derailment and lymphomagenesis. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Indexed as

Lymphoma, Large B-Cell, DiffuseSjogren's SyndromeHumansMemory B CellsMutationRheumatoid FactorRheumatoid FactorB cell lymphomabloodB LymphocyteMALTSjogren's syndrome

Identifiers

PMID36426826
PMCPMC10108009
OpenAlexW4309944706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.